Analysis of Industry 4.0 and Transformative Trends in Pharma

Abstract

Pharma 4.0 represents a disruptive force that is revolutionizing the pharmaceutical industry. It is presenting newer opportunities for innovation, and patient-centric care. The smart manufacturing driven by advanced technologies like Artificial Intelligence (AI), Robotics, Internet of Things (IoT), Big Data Analytics (BDA) seeks to integrate digital technologies and automation to create smart, connected manufacturing facilities. The given study examined the applications of AI, big data analytics, and IoT across drug development and marketing processes. The study has used qualitative analysis through NVivo 14 to analyze the secondary data collected from white papers, industry reports, and peer-reviewed research articles.  The findings suggested that data integrity, process innovation, and technology integration are critical dimensions for effective Pharma 4.0 implementation. Furthermore, strategy, technology, operations, culture, and people play crucial roles in driving this change. This study provides insights for stakeholders who want to leverage these technologies for improved efficiency and effectiveness in the pharmaceutical sector.